Global Microbial Cell-free DNA (mcfDNA) Detection Market Growth 2025-2031

The global Microbial Cell-free DNA (mcfDNA) Detection market size is predicted to grow from US$ 117 million in 2025 to US$ 169 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Compared with traditional microbial testing, microbial cell-free DNA (mcfDNA) testing has a higher positive rate. mcfDNA currently plays an important role in the diagnosis and treatment of clinical infections, such as sepsis, community-acquired pneumonia, tuberculosis, invasive fungal diseases, Urinary tract infection, infection after organ transplantation, etc.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Microbial Cell-free DNA (mcfDNA) Detection Industry Forecast” looks at past sales and reviews total world Microbial Cell-free DNA (mcfDNA) Detection sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbial Cell-free DNA (mcfDNA) Detection sales for 2025 through 2031. With Microbial Cell-free DNA (mcfDNA) Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbial Cell-free DNA (mcfDNA) Detection industry.

This Insight Report provides a comprehensive analysis of the global Microbial Cell-free DNA (mcfDNA) Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microbial Cell-free DNA (mcfDNA) Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbial Cell-free DNA (mcfDNA) Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbial Cell-free DNA (mcfDNA) Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbial Cell-free DNA (mcfDNA) Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbial Cell-free DNA (mcfDNA) Detection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Whole Blood
Plasma
Serum

Segmentation by Application:
Clinical Diagnosis
Food Safety and Production
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
illumina
BGI
Ion Torrent
nanopore sequencing

Key Questions Addressed in this Report

What is the 10-year outlook for the global Microbial Cell-free DNA (mcfDNA) Detection market?

What factors are driving Microbial Cell-free DNA (mcfDNA) Detection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Microbial Cell-free DNA (mcfDNA) Detection market opportunities vary by end market size?

How does Microbial Cell-free DNA (mcfDNA) Detection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Microbial Cell-free DNA (mcfDNA) Detection by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Microbial Cell-free DNA (mcfDNA) Detection by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings